• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Akari Therapeutics Plc (AKTX)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31																															2016-Mar-31	2015-Dec-31	2015-Sep-30	2015-Jun-30	2015-Mar-31	2014-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023																															Q1-FY2016	Q4-FY2015	Q3-FY2015	Q2-FY2015	Q1-FY2015	Q4-FY2014
Total Revenue
QoQ%
YoY%
Cost Of Revenue																																										23,000,000$	0$
Gross Profit																																										(23,000,000$)	0$
Gross Margin
Operating Expenses			3,227,000$	2,224,000$	3,119,000$	3,525,000$	4,296,000$	1,852,000$	5,555,000$	5,989,000$	5,091,000$	2,508,000$	4,616,000$	4,595,000$																												3,851,978$	4,290,950$	23,326,979$	1,456,000$	1,654,629$	1,105,139$	218,029$	2,330,000$
Operating Income			(3,227,000$)	(7,404,000$)	(3,119,000$)	(3,525,000$)	(5,278,000$)	(2,927,000$)	(7,449,000$)	(5,989,000$)	(5,090,000$)	(2,507,000$)	(4,615,000$)	(4,594,000$)																												(3,851,978$)	(4,290,950$)	(23,326,979$)	(1,456,000$)	(1,654,629$)	(1,105,139$)	(218,029$)	(2,330,000$)
Operating Margin
Interest Income			0$	1,000$			1,000$	3,000$	2,000$	2,000$	7,000$	16,000$	29,000$	30,000$																												30,804$	19,260$	1,445$		0$	6$	0$
Interest Expenses			0$	100,000$					51,000$																																	0$	(5,950$)	3,054,262$		4,556$	(2,111$)	2,882$
Income Before Tax			(5,213,000$)	(7,488,000$)	(1,895,000$)	(3,705,000$)	(3,772,000$)	(2,895,000$)	(7,558,000$)	(5,566,000$)	(4,138,000$)	(2,871,000$)	(4,000,000$)	1,001,000$																												(2,985,384$)	6,472,290$	(48,735,690$)	(1,671,000$)	(1,696,786$)	(1,113,811$)	(223,129$)	(2,229,000$)
Tax Expenses			85,000$	(1,088,000$)																																						0$	0$	0$	0$	0$	0$	0$	0$
Net Income			(5,298,000$)	(6,400,000$)	(1,895,000$)	(3,705,000$)	(3,772,000$)	(2,895,000$)	(7,558,000$)	(5,566,000$)	(4,138,000$)	(2,871,000$)	(4,000,000$)	1,001,000$																												(2,985,384$)	6,472,290$	(48,735,690$)	(1,671,000$)	(1,696,786$)	(1,113,811$)	(223,129$)	(2,229,000$)
Profit Margin
TTM
Earnings to Minority
Earnings to Common Shareholders			(5,298,000$)	(6,400,000$)	(1,895,000$)	(3,705,000$)	(3,772,000$)	(2,895,000$)	(7,558,000$)	(5,566,000$)	(4,138,000$)	(2,871,000$)	(4,000,000$)	1,001,000$																												(2,985,384$)	6,472,290$	(48,735,690$)	(1,671,000$)	(1,696,786$)	(1,113,811$)	(223,129$)	(2,229,000$)
QoQ%			17.22%	(237.73%)	48.85%	1.78%	(30.29%)	61.70%	(35.79%)	(34.51%)	(44.13%)	28.23%	(499.60%)																													(146.13%)	113.28%	(2,816.56%)	1.52%	(52.34%)	(399.18%)	89.99%	(28.10%)
YoY%			(40.46%)	(121.07%)	74.93%	33.44%	8.85%	(.84%)	(88.95%)	(656.04%)																																(75.94%)	681.09%	(21,741.93%)	25.03%	2.48%
Earnings Per Share, Basic			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$																												0.00$	0.00$	(0.06$)	(0.03$)	0.00$	(0.01$)	0.00$	(0.04$)
Earnings Per Share, Diluted			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$																												0.00$	0.00$	(0.06$)	(0.03$)	0.00$	(0.01$)	0.00$	(0.04$)
Unlevered FCF Per Share, Basic			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$																												(0.01$)	0.00$	0.01$	(0.02$)	0.00$	0.00$	0.05$	(0.04$)
Unlevered FCF Per Share, Diluted			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$																												(0.01$)	0.00$	0.01$	(0.02$)	0.00$	0.00$	0.05$	(0.04$)
Average Shares, Basic			86,454,098,348	65,326,236,698	62,943,895,665	54,588,283,841	38,876,409,461	24,386,005,523	18,836,478,977	13,453,147,979	11,449,464,694	10,116,903,598	10,115,005,727	7,474,546,753																												1,177,693,383	1,848,633,448	781,738,789	55,636,283	722,345,600	163,582,851	73,370,267	55,636,283
Average Shares, Diluted			86,454,098,348	65,326,236,698	62,943,895,665	54,588,283,841	38,876,409,461	24,386,005,523	18,836,478,977	13,453,147,979	11,350,468,990	10,116,903,598	10,115,005,727	7,573,542,457																												1,177,693,383	1,848,633,448	781,738,789	55,636,283	722,345,600	163,582,851	73,370,267	55,636,283
EBIT			(5,213,000$)	(7,388,000$)	(1,895,000$)	(3,705,000$)	(3,772,000$)	(2,895,000$)	(7,507,000$)	(5,566,000$)	(4,138,000$)	(2,871,000$)	(4,000,000$)	1,001,000$																												(2,985,384$)	6,466,340$	(45,681,428$)	(1,671,000$)	(1,692,230$)	(1,115,922$)	(220,247$)	(2,229,000$)
EBITDA			(5,213,000$)	(7,388,000$)	(1,895,000$)	(3,705,000$)	(3,771,000$)	(2,895,000$)	(7,507,000$)	(5,553,000$)	(4,137,000$)	(2,870,000$)	(3,999,000$)	1,002,000$																												(2,985,384$)	6,466,340$	(45,681,428$)	(1,671,000$)	(1,692,230$)	(1,115,922$)	(220,247$)	(2,229,000$)

Copy Table ✓